Head-to-head comparisons of medication uses, side effects, warnings, and more.
Zepbound (tirzepatide)
Wegovy (semaglutide)
Zepbound (tirzepatide)
Wegovy (semaglutide)
Summary of Zepbound vs. Wegovy
Summary for GIP and GLP-1 agonist
Prescription only
Zepbound, a brand name for tirzepatide, is an injectable medication that's used along with diet and exercise to help with weight loss. It's approved for certain adults who meet criteria for weight management therapy. Zepbound (tirzepatide) is also approved to treat moderate-to-severe sleep apnea. This medication belongs to the drug class called GIP and GLP-1 agonists. The typical dosage is 1 injection under the skin once per week. Common side effects include nausea, diarrhea, stomach pain, and injection site reactions.
Summary for GLP-1 agonist
Prescription only
Wegovy (semaglutide) is used in addition to a lower-calorie diet and exercise plan to help with weight loss in certain adults and children 12 years of age and older. It's also proven to lower the risk for heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease. This medication belongs to the drug class called glucagon-like peptide-1 (GLP-1) receptor agonists. The dosing schedule for Wegovy (semaglutide) is once a week, and the medication is injected under your skin. Common side effects include nausea, diarrhea, and stomach pain.